title: Syzygium cumini is more effective in preventing the increase of erythrocytic ADA activity than phenolic compounds under hyperglycemic conditions in vitro.
abstract: Syzygium cumini (S. cumini) is a plant known for its antidiabetic properties. The aim of this study was to evaluate the effect of Sc aqueous leaf extract (ASc) on adenosine deaminase (ADA) activity in erythrocytes (RBCs) exposed to high glucose concentrations (30 mM) in vitro. We also investigated the effects of the main phenolic compounds found in ASc (gallic acid, rutin, and chlorogenic acid) and the effects of insulin, caffeine, and dipyridamole, which are substances involved in the adenosine metabolism, on ADA activity in vitro. Blood samples were obtained from healthy volunteers and a suspension of RBCs was used for the determination of ADA activity. The results showed that: (1) the effect of ASc on ADA activity was more significant than the combination of phenolic compounds; (2) insulin, caffeine, or dipyridamole prevented high glucose increase of ADA activity at doses as low as 50 μU/mL, 25 μM, and 1 μM, respectively; (3) the inhibitory effect caused by ASc on erythrocyte ADA activity remained practically the same after the combination of the extract with insulin or caffeine; (4) when RBCs were exposed to ASc plus dipyridamole, this chemical attenuated the effect of ASc on ADA activity, suggesting an antagonism or a competition with ASc by the same site of action. Therefore, ASc was more effective in preventing the increase in ADA activity than phenolic compounds, suggesting that ASc may collaborate to improve endothelial dysfunction, antioxidant, anti-inflammatory, and antithrombotic properties of adenosine by affecting its metabolism. The results of this study help to provide evidence of the empirically supported benefits of the use of S. cumini in diabetes.
authors.affiliation: Postgraduate Program in Pharmacology, Department of Clinical and Toxicology Analysis, Center of Health Sciences, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
authors.forename: Karine S
authors.initials: KS
authors.lastname: De Bona
authors.forename: Gabriela
authors.initials: G
authors.lastname: Bonfanti
authors.forename: Paula E R
authors.initials: PE
authors.lastname: Bitencourt
authors.forename: Lariane O
authors.initials: LO
authors.lastname: Cargnelutti
authors.forename: Priscila S
authors.initials: PS
authors.lastname: da Silva
authors.forename: Thainan P
authors.initials: TP
authors.lastname: da Silva
authors.forename: Régis A
authors.initials: RA
authors.lastname: Zanette
authors.forename: Aline S
authors.initials: AS
authors.lastname: Pigatto
authors.forename: Maria B
authors.initials: MB
authors.lastname: Moretto
mesh_terms: D000243:Adenosine Deaminase / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D006943:Hyperglycemia / Q000097:blood*; D066298:In Vitro Techniques; D010636:Phenols / Q000494:pharmacology*; D010936:Plant Extracts / Q000494:pharmacology*; D027842:Syzygium / Q000737:chemistry*
chemical_list: D010636:Phenols; D010936:Plant Extracts; D000243:Adenosine Deaminase